Canada Pension Plan Investment Board’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
9,504
-21,100
-69% -$1.38M ﹤0.01% 1023
2026
Q1
$242K Sell
30,604
-12,996
-30% -$210K ﹤0.01% 1502
2025
Q4
$751K Buy
43,600
+36,140
+484% +$701K ﹤0.01% 1156
2025
Q3
$192K Buy
7,460
+6,928
+1,302% +$262K ﹤0.01% 1121
2025
Q2
$30.6K Sell
532
-1,612
-75% -$129K ﹤0.01% 1292
2025
Q1
$232K Sell
2,144
-1,868
-47% -$163K ﹤0.01% 1038
2024
Q4
$191K Buy
+4,012
New +$243K ﹤0.01% 1191
2023
Q1
Sell
-560
Closed -$226K 1056
2022
Q4
$226K Sell
560
-4,464
-89% -$2.09M ﹤0.01% 976
2022
Q3
$2.94M Buy
5,024
+1,336
+36% +$800K 0.01% 611
2022
Q2
$2.01M Buy
3,688
+1,568
+74% +$793K ﹤0.01% 684
2022
Q1
$1.34M Buy
+2,120
New +$1.09M ﹤0.01% 799

Other funds holding AGL

Canada Pension Plan Investment Board's AGL Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Agilon Health (AGL) stake by 69% in Q2 2026, selling an estimated $1.38M and leaving 9,504 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Canada Pension Plan Investment Board first reported a position in AGL in Q1 2022 and has held it in 11 quarters since. The position peaked at $2.94M in Q3 2022. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Canada Pension Plan Investment Board held 9,504 shares of Agilon Health worth $1.02M as of Q2 2026.
  • Canada Pension Plan Investment Board sold 21,100 Agilon Health shares in Q2 2026, an estimated $1.38M.
  • Agilon Health made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1023 holding.
  • Canada Pension Plan Investment Board first reported a position in Agilon Health in Q1 2022 and has held it in 11 quarters since.
  • Canada Pension Plan Investment Board's Agilon Health position peaked at $2.94M in Q3 2022.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.